Eontec got CE certification for Magnesium Bone Screw
Biodegradable Screw will be perfect complementary technology for RTEMD (Real Time Embedded Medical Devices) of which BMG wanted to be ME TOO offering to Stainless Steel / Titanium.
With ME ONLY complementary Biodegradable Screw, it will allow the creation of ME ONLY (one time surgical) Embedded Orthopedic Medical System. https://aabme.asme.org/posts/innovations-in-orthopedic-devices-and-procedure-improvement-solutions-to-transform-the-industry Smart implants have embedded sensors that provide real-time information to surgeons for positioning and post-operative evaluation for better patient care throughout the treatment pathway. These implants have the potential to reduce peri-prosthetic infection, which is a growing problem in orthopedic practice. Sensor-enabled technologies have given health care providers a choice of unique, cost-effective products. https://pdf.dfcfw.com/pdf/H2_AN202005181379889780_1.pdf
Stock code: 300328
Stock abbreviation: Eonted
Announcement No .: 2020-041
Announcement that the company's degradable magnesium bone internal fixation screw has obtained CE certification
All members of the company and the board of directors guarantee that the information disclosed is true, accurate and complete, and there are no false records, misleading statements or major omissions.
Eontec, Ltd. (hereinafter referred to as "Eontec" or "Company") has recently received the CE certification of the company's degradable magnesium internal fixation screw issued by the international authoritative EU certification announcement body UDEM The announcement is as follows:
1. CE certification
Full Quality Assurance System Certificate
Degradable magnesium internal fixation screw
Bone flap fixation in the field of orthopedics
2. Impact on the company and risk warning
Globally, the company obtained the first approval certificate for this indication product. The company's degradable magnesium bone internal fixation screw obtained CE certification certificate shows that the product meets the relevant requirements of the European Union, and already has the access conditions for the EU market. Development has a positive impact.
Due to the high-tech, high-risk and high-value-added features of medical device products, the actual sales of the above products after production may be affected by factors such as future market promotion effects and changes in market environment. Investors are invited to pay attention and pay attention to investment risks for the impact of performance.
Board of Directors
May 18, 2020